论文部分内容阅读
目的:探讨氨溴索治疗哮喘性支气管炎的临床分析;方法:选取2013年1月至2014年12月期间在我院接受治疗的90例哮喘性支气管炎患者作为研究对象,将其随机分成观察组45例(氨溴索治疗)和对照组45例(常规治疗),对比两组患者的临床效果;结果:观察组患者的治疗有效率为95.56%,对照组的治疗有效率为75.56%,两组在治疗效果、临床症状消失的时间方面相比差异具有显著性(P<0.05);结论:在常规的治疗基础上加上氨溴索,对哮喘性支气管炎患者进行治疗,效果明显,安全性高,可在临床上进行广泛的使用,以便于更好的解救患者。
OBJECTIVE: To investigate the clinical analysis of ambroxol in the treatment of asthmatic bronchitis.Methods: Ninety asthmatic bronchitis patients treated in our hospital from January 2013 to December 2014 were selected as the study subjects and randomly divided into observation 45 cases (ambroxol treatment) and 45 cases (control group) were enrolled in this study. The clinical effects were compared between the two groups. Results: The effective rate was 95.56% in the observation group and 75.56% in the control group, There was significant difference between the two groups in terms of the time of treatment and disappearance of clinical symptoms (P <0.05). CONCLUSION: Ambroxol is added to the conventional treatment for patients with asthmatic bronchitis, the effect is obvious, High safety, can be widely used in clinical, in order to better rescue patients.